Emeramed Ltd, Corporation just released form D for $274,217 equity financing. This is a new filing. Emeramed was able to finance itself with $274,217. That is 100.00% of the fundraising offer. The total fundraising amount was $274,217. The offering form was filed on 2016-11-15. The reason for the financing was: Amounts sold reflect all sales made in reliance upon exemption claimed in this Form D. All investments in Euros have been converted to US Dollars as of the transaction date..
Emeramed is based in Sweden. The filler’s business is Pharmaceuticals. The form D was submitted by J Todd Renner Chief Financial Officer. The company was incorporated in 2014. The filler’s address is: 7/8 Wilton Terrace, Dublin, L2, Ireland, 2. Boyd E Haley is the related person in the form and it has address: Coldstream Research Campus, 1648 Mcgrathiana Pkwy, Suite 310, Lexington, Ky, Kentucky, 40511-1340. Link to Emeramed Filing: 000162341616000004.
Analysis of Emeramed Offering
On average, startups in the Pharmaceuticals sector, sell 60.90% of the total offering amount. Emeramed sold 100.00% of the offering. Could this mean that the trust in Emeramed is high? The average fundraising size for companies in the Pharmaceuticals industry is $556,000. The offering was 50.68% smaller than the average of $556,000. Of course this should not be seen as negative. Startups get financed for a variety of needs and reasons. The minimum investment for this offering was set at $1000. If you know more about the reasons for the fundraising, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Emeramed Also
The Form D signed by J Todd Renner might help Emeramed Ltd’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.